Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

Homecompany Pregabalin CAS 148553-50-8
 Pregabalin
 Pregabalin
 Pregabalin
 Pregabalin
 Pregabalin
 Pregabalin

Pregabalin CAS 148553-50-8

Price USD70.00
Packge 1KG
  • Min. Order:2KG
  • Supply Ability:>1000kg
  • Time:2021-08-10

Product Details

  • Product Name Pregabalin
  • CAS No.148553-50-8
  • EINECS No.200-002-5
  • MFC8H17NO2
  • MW159.23
  • Appearancewhite powder
  • Melting point 194-196°C
  • storage temp. 2-8°C
  • Boiling point 274.0±23.0 °C(Predicted)
  • density 0.997±0.06 g/cm3(Predicted)
  • Water Solubility Soluble to 100 mM in water
Product Name:Pregabalin
Synonyms:3(S)-(AMINOMETHYL)-5-METHYLHEXANOIC ACID;(3S)-3-(AMINOMETHYL)-5-METHYLHEXANOIC ACID;PREGABALIN;Pregablin;3-(Aminomethyl)-5-methyl-hexanoic acid;PREDNISOLONESODIUMPHOSPHATE;(R)-Pregabalin;(S)-Pregabalin
CAS:148553-50-8
MF:C8H17NO2
MW:159.23
EINECS:604-639-1
Product Categories:Miscellaneous Biochemicals;APIs;Intermediates & Fine Chemicals;Neurochemicals;Pharmaceuticals;API;Pfizer compounds;LYRICA;pharmaceutical
Mol File:148553-50-8.mol
Pregabalin Structure

Pregabalin Chemical PropertiesMelting point 194-196°Calpha D23 +10.52° (c = 1.06 in water)Boiling point 274.0±23.0 °C(Predicted)density 0.997±0.06 g/cm3(Predicted)Fp 9℃storage temp. Store at RTsolubility deionized water: ≥10mg/mLpka4.23±0.10(Predicted)form white powderInChIKeyAYXYPKUFHZROOJ-ZETCQYMHSA-NCAS DataBase Reference148553-50-8(CAS DataBase Reference)

Safety InformationHazard Codes Xn,T,FRisk Statements 63-48/22-39/23/24/25-23/24/25-11Safety Statements 22-36/37-45-16-7RIDADR UN1230 - class 3 - PG 2 - Methanol, solutionWGK Germany 3HS Code 29224999Hazardous Substances Data148553-50-8(Hazardous Substances Data)
MSDS Information

Pregabalin Usage And SynthesisDescriptionPregabalin is a second- generation antiepileptic drug (AED) known with the proprietary brand name of Lyrica® (Pfizer, Tadworth) in the UK and USA (Pfizer, New York, NY).Generic formulationMHRA/ CHM advice to minimize risk when switching patients with epilepsy between different manufacturers’ products (including generic products):
  • It is usually unnecessary to ensure that patients are maintained on a specific manufacturer’s product unless there are specific concerns, such as patient anxiety and risk of confusion/ dosing error.

IndicationsEpilepsy
Adjunctive therapy of focal seizures with and without secondary generalization.

Recommendations summarized from NICE (2012)
  • Seizure types—on referral to tertiary care (focal seizures), contraindicated (generalized tonic- clonic seizures, tonic/ atonic seizures, absence seizures, myoclonic seizures).

  • Epilepsy types—on referral to tertiary care (benign epilepsy with centrotemporal spikes, panayiotopoulos syndrome, late- onset childhood occipital epilepsy), contraindicated (absence syndromes, idiopathic generalized epilepsy, juvenile myoclonic epilepsy, Dravet syndrome, Lennox– Gastaut syndrome).


Psychiatry
Generalized anxiety disorder.

Neurology
Peripheral and central neuropathic pain.
Dose titration
  • Epilepsy— adjunctive therapy: 25 mg bd for 7 days, to be increased by 50 mg every 7days; usual maintenance 300 mg daily, divided into 2 or 3 doses (max. 600 mg daily, divided into 2 or 3 doses).

  • Generalized anxiety disorder: 150 mg daily, divided into 2 or 3 doses, for 7 days, to be increased by 150 mg every 7 days (max. 600 mg daily, divided into 2 or 3 doses).

If stopping pregabalin, it is recommended to taper over at least 1 week to avoid abrupt withdrawal.
Plasma levels monitoringPregabalin pharmacokinetics are linear over the recommended daily dose range; inter- subject pharmacokinetic variability for pregabalin is low (<20%) and multiple dose pharmacokinetics are predictable from single- dose data. Therefore, there is no need for routine monitoring of plasma concentrations of pregabalin.
Hot selling :

Company Profile Introduction

Shijiazhuang Tongyang Import and Export Co., LTD , located in Shijiazhuang City,which is the capital of Hebei Province and hub sector among Beijing, Tianjin, and Hebei.We have the advantage of convenient transportation.Our company is a modern high-tech chemical enterprise with Research & Development, production and sales.In recent five years, the company has implemented the strategy of "going out" vigorously.We has established our branches in Hubei China, Vietnam and Mexico, making our market and sales network more and more perfect.Our company will continue to adhere to the strategic positioning of fine chemical industry in the future and competition ideas of irreplaceable product differentiation,and strive to become to the leading of Chinese chemical industry.Shijiazhuang Tongyang Import and Export Co., LTD , located in Shijiazhuang City,which is the capital of Hebei Province and hub sector among Beijing, Tianjin, and Hebei.We have the advantage of convenient transportation.Our company is a modern high-tech chemical enterprise with Research & Development, production and sales.In recent five years, the company has implemented the strategy of "going out" vigorously.We has established our branches in Hubei China, Vietnam and Mexico, making our market and sales network more and more perfect.Our company will continue to adhere to the strategic positioning of fine chemical industry in the future and competition ideas of irreplaceable product differentiation,and strive to become to the leading of Chinese chemical industry.

  • Since:2015-05-06
  • Address: room 1916,haiyuetiandi,66 yuehua west road,xiaoxi district
INQUIRY